Allplex™ 2019-nCoV Assay* (EUA)
Targets
- SARS-CoV-2 (E gene)
- SARS-CoV-2 (RdRP gene)
- SARS-CoV-2 (N gene)
Description
Targets 3
Sample Type
- Nasopharyngeal swab
- Nasopharyngeal aspirate
- Bronchoalveolar lavage (BAL)
- Oropharyngeal (throat) swab
- Saliva
- Sputum (Respiratory Panel 4 only)
- Cultured cells
- Fresh tissue
Key Features
- A single test for the detection of multiple respiratory tract targets.
- Short TAT (4 hours) from extraction to final results for up to 4 respiratory infection panels in unison
- Informative data with individual Ct reporting for each analyte
Compatible instrumentation
Automated Extraction & PCR Setup
- Seegene NIMBUS
- Seegene STARlet
Real-time PCR
- CFX96 Real-Time PCR Detection System (Bio-Rad)
- CFX96 Dx System (Bio-Rad)
- CFX96 Opus (Bio-Rad)
- CFX96 Touch Real-Time PCR Detection System (Bio-Rad)
Seegene Viewer Software
- Quick and easy data analysis and interpretation
- Interface specialized for multiplex testing
• Allplex™ 2019-nCoV Assay has an Emergency Use Authorization in the U.S. • Seegene NIMBUS, Seegene STARlet, Seegene Launcher and Viewer software are For Research Use Only. Not for Use in Diagnostic Procedures.
Additional information
Volume | 100 rxns, 124 rxns |
---|